Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases
- 1 March 2004
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 147 (2) , 129-139
- https://doi.org/10.1016/j.cbi.2003.12.001
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- New antiretroviral drugsClinical Microbiology & Infection, 2003
- The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymesChemico-Biological Interactions, 2002
- Patented small molecule inhibitors of HIV-1 integrase: a 10-year sagaExpert Opinion on Therapeutic Patents, 2002
- New Developments in Anti-HIV ChemotherapyCurrent Medicinal Chemistry, 2001
- Unexploited viral and host targets for the treatment of human immunodeficiency virus type 1 infection.Current Drug Targets - Infectious Disorders, 2001
- Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactionsToxicology, 2000
- Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosolXenobiotica, 2000
- THE RETROVIRAL ENZYMESAnnual Review of Biochemistry, 1994
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988
- Molecular organization of the AIDS retrovirusCell, 1985